Comment on "Secukinumab drug survival in patients with psoriasis: A multicenter, real-world, retrospective study"

J Am Acad Dermatol. 2019 Sep;81(3):e81-e82. doi: 10.1016/j.jaad.2019.04.072. Epub 2019 May 18.

Authors

Laura Palacios-García¹, Celia Gómez-de Castro¹, Marc Mir-Bonafé¹, Cristina Calzón², Cristina Galache¹, Jorge Santos-Juanes³

Affiliations

¹ Department of Dermatology, Hospital Universitario Central de Asturias, Oviedo, Spain.
² UGC Farmacia, Hospital Universitario Central de Asturias, Oviedo, Spain.
³ Department of Dermatology, Hospital Universitario Central de Asturias, Oviedo, Spain; Dermatology, Department of Medicine, University of Oviedo, Oviedo, Spain. Electronic address: jorgesantosjuanes@gmail.com.

PMID: 31112727
DOI: 10.1016/j.jaad.2019.04.072

No abstract available

Publication types

Letter
Comment

MeSH terms

Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Humans
Psoriasis*
Retrospective Studies

Substances

Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
secukinumab